The size of angel financing rounds in the healthcare industry grew last year, although the share of all angel deals focused on healthcare stayed about the same.
Silicon Valley Bank, the Angel Resource Institute and CB Insights are out with their 2013 Halo Report today looking back at last year’s trends. The data showed deals rebounding from a dip in 2012 and becoming increasingly valuable.
In healthcare, median deal size rose from $1.1 million in 2012 to $1.6 million in 2013.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Here are the country’s most active angel groups, according to SVP, ARI and CB Insights, and who they’re backing in healthcare.
Golden Seeds (Avaxia Biologics, Lark)
Tech Coast Angels (Active Life Scientific, Avaxia Biologics, Cadence Biomedical)
Houston Angel Network (Adient Medical, OrthoAccel)
Central Texas Angel Network (Xeris Pharmaceuticals, Savara Pharmaceuticals)
Sand Hill Angels (Ark Diagnostics, Cadece Biomedical, MyHealthTeams)
Launchpad Venture Group (Qstream, Cognoptix)
New York Angels (UroValve, CogRx)
Desert Angels (Sialix, SynCaria)
Investors’ Circle (Bioceptive, Validic)
Alliance of Angels (FlexMinder, ClarityHealth)